4basebio PLC (88Q.DE)
EUR 14.6
(0.0%)
EUR 14.6
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -6.17 Million | -4.7 Million | -2.74 Million | -1.02 Million | -269 Thousand |
| Net Income | -7.66 Million | -5.15 Million | -3.23 Million | -719 Thousand | -423 Thousand |
| Depreciation & Amortization | 709 Thousand | 431 Thousand | 320 Thousand | 277 Thousand | 251 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 384 Thousand | 168 Thousand | 455 Thousand | -809 Thousand | -38 Thousand |
| Other non-cash items | 522 Thousand | -153 Thousand | -280 Thousand | 229 Thousand | -59 Thousand |
| Investing Cash Flow | -1.49 Million | -1.94 Million | -1.51 Million | 1.44 Million | -203 Thousand |
| Investments in PPE | -1.49 Million | -1.94 Million | -1.51 Million | -849 Thousand | -203 Thousand |
| Acquisitions | - | - | - | 2.29 Million | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -619 Thousand | - | - | - | - |
| Financing Cash Flow | 6.42 Million | 1.24 Million | -467 Thousand | 14.42 Million | 487 Thousand |
| Debt repayment | -6.58 Million | -1.41 Million | -331 Thousand | -1.02 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 2000.00 | - | - | 15.62 Million | - |
| Other Financing Activities | -161 Thousand | - | -136 Thousand | -175 Thousand | 487 Thousand |
| Accounts receivables | -109 Thousand | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -202 Thousand | 30 Thousand | -34 Thousand | -24 Thousand | 13 Thousand |
| Other working capital | 695 Thousand | 138 Thousand | 489 Thousand | -785 Thousand | -51 Thousand |
| Cash at beginning of period | 4.35 Million | 9.58 Million | 15 Million | 80 Thousand | 69 Thousand |
| Cash at end of period | 3.06 Million | 4.35 Million | 9.58 Million | 15 Million | 80 Thousand |
| Capital Expenditure | -1.49 Million | -1.94 Million | -1.51 Million | -849 Thousand | -203 Thousand |
| Effect of forex changes on cash | -39 Thousand | 166 Thousand | -696 Thousand | 70 Thousand | -4000.00 |
| Net cash flow / Change in cash | -1.28 Million | -5.23 Million | -5.41 Million | 14.92 Million | 11 Thousand |
| Free Cash Flow | -7.66 Million | -6.64 Million | -4.25 Million | -1.87 Million | -472 Thousand |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.76 Million | -7.66 Million | -4.74 Million | -4.13 Million | -5.15 Million | -3.07 Million |
| Depreciation & Amortization | 605.52 Thousand | 709 Thousand | 435.96 Thousand | 385.18 Thousand | 431 Thousand | 216.96 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -317.51 Thousand | 384 Thousand | 675.86 Thousand | -235.06 Thousand | 168 Thousand | 245.21 Thousand |
| Other non-cash items | 342.3 Thousand | 522 Thousand | 96.88 Thousand | 1.48 Million | -153 Thousand | 186.45 Thousand |
| Investing Cash Flow | -820.34 Thousand | -1.49 Million | -869.62 Thousand | -856.48 Thousand | -1.94 Million | -641.84 Thousand |
| Investments in PPE | -221.9 Thousand | -1.49 Million | -869.62 Thousand | -856.48 Thousand | -1.94 Million | -641.84 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 6.55 Million | 6.42 Million | 3.86 Million | 3.65 Million | 1.24 Million | 1.86 Million |
| Debt repayment | -5.71 Million | -6.58 Million | -3.91 Million | -3.7 Million | -1.41 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 875.82 Thousand | 2000.00 | - | 2327.41 | - | - |
| Other Financing Activities | -43.67 Thousand | - | -51.9 Thousand | -57.02 Thousand | - | 307.36 Thousand |
| Accounts receivables | -64.91 Thousand | - | -5766.76 | -121.02 Thousand | - | 402.28 Thousand |
| Accounts payables | -212.46 Thousand | - | 833.87 Thousand | -32.58 Thousand | - | -179.67 Thousand |
| Inventory | -40.13 Thousand | -202 Thousand | -152.24 Thousand | -81.45 Thousand | 30 Thousand | 22.6 Thousand |
| Other working capital | - | - | - | -1.00 | 138 Thousand | - |
| Cash at beginning of period | 3.53 Million | 4.35 Million | 4.14 Million | 4.91 Million | 9.58 Million | 6.5 Million |
| Cash at end of period | 3.2 Million | 3.06 Million | 3.53 Million | 4.14 Million | 4.35 Million | 4.91 Million |
| Capital Expenditure | -221.9 Thousand | -1.49 Million | -869.62 Thousand | -856.48 Thousand | -1.94 Million | -641.84 Thousand |
| Effect of forex changes on cash | - | -39 Thousand | - | -67.54 Thousand | 166 Thousand | -188.96 Thousand |
| Net cash flow / Change in cash | -331.43 Thousand | -1.28 Million | -600.82 Thousand | -776.23 Thousand | -5.23 Million | -1.58 Million |
| Free Cash Flow | -6.35 Million | -7.66 Million | -4.59 Million | -4.36 Million | -6.64 Million | -3.25 Million |
1592
BCAUF
9384
044380
GAM-PB
102710